April 24, 2019 (MLN): GSK Consumer Healthcare Pakistan Ltd (GSKCH) has issued its financial earnings result for the quarter ended on March 31, 2019, as per which the company has earned net profits of Rs.167.3 million (EPS: Rs.1.43), i.e. around 38% lower as compared to the same period last year.
The decline in earnings was a direct result of increase in cost of sales, which amplified by 15% and decline in other income by 48%, whereas sales revenue increased by 7% only.
Regrettably, the decline in operating expenses by 30.4%, finance cost by 42% and tax payments by 22% failed to alleviate the negative impact of increased costs of sales and lesser other income.
|
Financial Results for the Quarter Ended March 31, 2019 (Rupees) |
|||
|---|---|---|---|
|
|
Mar-19 |
Mar-18 |
% Change |
|
Sales |
3,872,871,492 |
3,628,148,463 |
6.75% |
|
Cost of Sales |
(2,799,319,548) |
(2,430,177,900) |
15.19% |
|
Gross Profit |
1,073,551,944 |
1,197,970,563 |
-10.39% |
|
Selling, marketing and distribution expenses |
(697,075,958) |
(665,105,230) |
4.81% |
|
Administrative expenses |
(71,130,949) |
(72,878,182) |
-2.40% |
|
Other operating expenses |
(22,449,200) |
(32,282,765) |
-30.46% |
|
Other income |
11,002,169 |
21,035,088 |
-47.70% |
|
Profit from operations |
293,898,006 |
448,739,474 |
-34.51% |
|
Finance cost |
(38,135,246) |
(66,711,272) |
-42.84% |
|
255,762,760 |
382,028,202 |
-33.05% |
|
|
Taxation |
(88,448,076) |
(113,286,910) |
-21.93% |
|
Profit after taxation from continuing operations |
167,314,684 |
268,741,292 |
-37.74% |
|
(Loss)/Profit after taxation from discontinued operations |
– |
– |
|
|
Total profit after taxation |
167,314,684 |
268,741,292 |
-37.74% |
|
Earnings per share (Rupees) |
1.43 |
2.30 |
-37.83% |
Copyright Mettis Link News
27628
